A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies

MLA

Andrew Picken, et al. “A Monte Carlo Framework for Managing Biological Variability in Manufacture of Autologous Cell Therapy from Mesenchymal Stromal Cells Therapies.” Cytotherapy, vol. 22, no. 4, Sept. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ee9957d954c0d5a719ed68d87a61f998&authtype=sso&custid=ns315887.

APA

Andrew Picken, Amy Prosser, Andreea Iftimia-Mander, Robin Quirk, J. Harriman, Robert Thomas, & Lyndsey Johnson. (2019). A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies. Cytotherapy, 22(4).

Chicago

Andrew Picken, Amy Prosser, Andreea Iftimia-Mander, Robin Quirk, J. Harriman, Robert Thomas, and Lyndsey Johnson. 2019. “A Monte Carlo Framework for Managing Biological Variability in Manufacture of Autologous Cell Therapy from Mesenchymal Stromal Cells Therapies.” Cytotherapy 22 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ee9957d954c0d5a719ed68d87a61f998&authtype=sso&custid=ns315887.